Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
    1.
    发明授权
    Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines 有权
    减毒的人 - 牛嵌合副流感病毒(PIV)疫苗

    公开(公告)号:US07632508B2

    公开(公告)日:2009-12-15

    申请号:US11324284

    申请日:2006-01-04

    IPC分类号: A61K39/12 A61K39/155

    摘要: Chimeric human-bovine parainfluenza viruses (PIVs) are infectious and attenuated in humans and other mammals and useful individually or in combination in vaccine formulations for eliciting an immune response to PIV or other pathogens. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a partial or complete human or bovine PIV “background” genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) of a different PIV. Chimeric human-bovine PIV of the invention include a partial or complete “background” PIV genome or antigenome derived from or patterned after a human or bovine PIV virus combined with one or more heterologous gene(s) or genome segment(s) of a different pathogen, including different PIV virus to form the human-bovine chimeric PIV genome or antigenome.

    摘要翻译: 嵌合人 - 牛副流感病毒(PIV)在人类和其他哺乳动物中是感染性和减毒性的,并且在疫苗制剂中单独使用或组合用于引发对PIV或其它病原体的免疫应答。 还提供了分离的多核苷酸分子和掺入嵌合PIV基因组或抗原组的载体,其包括部分或完整的人或牛PIV“背景”基因组或反基因组,其与一个或多个异源基因或基因组片段组合或整合, 不同的PIV。 本发明的嵌合人牛PIV包括部分或完整的“背景”PIV基因组或反义基因组,其衍生自或构图在人或牛PIV病毒与一个或多个异源基因或不同基因组的基因组片段组合 病原体,包括不同的PIV病毒,以形成人 - 牛嵌合PIV基因组或抗原组。

    Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
    2.
    发明授权
    Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines 有权
    减毒的人 - 牛嵌合副流感病毒(PIV)疫苗

    公开(公告)号:US07622123B2

    公开(公告)日:2009-11-24

    申请号:US10982223

    申请日:2004-11-04

    IPC分类号: A61K39/155

    摘要: Chimeric human-bovine parainfluenza viruses (PIVs) are infectious and attenuated in humans and other mammals and useful individually or in combination in vaccine formulations for eliciting an anti-PIV immune response. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a partial or complete human or bovine PIV “background” genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) of a different PIV. Chimeric human-bovine PIV of the invention include a partial or complete “background” PIV genome or antigenome derived from or patterned after a human or bovine PIV virus combined with one or more heterologous gene(s) or genome segment(s) of a different PIV virus to form the human-bovine chimeric PIV genome or antigenome.

    摘要翻译: 嵌合人 - 牛副流感病毒(PIV)在人类和其他哺乳动物中具有感染性和减毒性,并且在疫苗制剂中单独使用或组合用于引发抗PIV免疫应答。 还提供了分离的多核苷酸分子和掺入嵌合PIV基因组或抗原组的载体,其包括部分或完整的人或牛PIV“背景”基因组或反基因组,其与一个或多个异源基因或基因组片段组合或整合, 不同的PIV。 本发明的嵌合人牛PIV包括部分或完整的“背景”PIV基因组或反义基因组,其衍生自或构图在人或牛PIV病毒与一个或多个异源基因或不同基因组的基因组片段组合 PIV病毒形成人 - 牛嵌合PIV基因组或抗原组。

    Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
    5.
    发明授权
    Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines 有权
    减毒的人 - 牛嵌合副流感病毒(PIV)疫苗

    公开(公告)号:US07201907B1

    公开(公告)日:2007-04-10

    申请号:US09586479

    申请日:2000-06-01

    IPC分类号: A61K39/12 A61K39/155

    摘要: Chimeric human-bovine parainfluenza viruses (PIVs) are infectious and attenuated in humans and other mammals and useful individually or in combination in vaccine formulations for eliciting an anti-PIV immune response or as vectors for introducing heterologous genes into a host. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a partial or complete human or bovine PIV “background” genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) of a different PIV. Chimeric human-bovine PIV of the invention include a partial or complete “background” PIV genome or antigenome derived from or patterned after a human or bovine PIV virus combined with one or more heterologous gene(s) or genome segment(s) of a different PIV virus to form the human-bovine chimeric PIV genome or antigenome.

    摘要翻译: 嵌合人 - 牛副流感病毒(PIV)在人类和其他哺乳动物中具有感染性和减毒性,并且在疫苗制剂中单独使用或组合用于引发抗PIV免疫应答或作为将异源基因导入宿主的载体。 还提供了分离的多核苷酸分子和掺入嵌合PIV基因组或抗原组的载体,其包括部分或完整的人或牛PIV“背景”基因组或反基因组,其与一个或多个异源基因或基因组片段组合或整合, 不同的PIV。 本发明的嵌合人牛PIV包括部分或完整的“背景”PIV基因组或反义基因组,其衍生自或构图在人或牛PIV病毒与一个或多个异源基因或不同基因组的基因组片段组合 PIV病毒形成人 - 牛嵌合PIV基因组或抗原组。